Clinical Trial Update: A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN) [Phase 2]

View source ↗

Summary

Phase 2 chemoprevention trial of an investigational GTx drug in men with high-grade prostatic intraepithelial neoplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostatic Intraepithelial Neoplasia

Drugs mentioned

• GTx investigational agent (name not disclosed)

Snippet

Sponsor: GTx | Conditions: Prostatic Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED